Tetralogy of Fallot
59
9
14
24
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.8%
4 terminated out of 59 trials
85.7%
-0.8% vs benchmark
3%
2 trials in Phase 3/4
29%
7 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (59)
Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
Contrast Enhanced 3D Echocardiographic Quantification of Right Ventricular Volumes in Repaired CHD
PULSTA Transcatheter Pulmonary Valve Pre-Approval Study
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
High Intensity Interval Training in Patients With a Right Ventricle to Pulmonary Artery Conduit
Beta-blocker Administration for Cardiomyocyte Division
ALTERRA Post-Approval Study
ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent
Role of 3D Echocardiography Knowledge-based Reconstruction in ACHD
NIRS in Congenital Heart Defects - Correlation With Echocardiography
Effects Branch PA Stenting d-TGA, ToF and TA
Haemodynamics and Function of the Atria in Congenital Heart Disease by Cardiovascular Magnetic Resonance
Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period
Repaired Tetralogy of Fallot Italian Registry
Lymphatic Magnetic Resonance Imaging Abnormalities in Children With Tetralogy of Fallot: A Case-Control Study
Predictors of Aortic Root Dilatation in Tetralogy of Fallot Patients
Pediatric REPlAcement of the PulmonaRy ValvE in Tetralogy of Fallot -
The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot
Prognostic Value of NLR, TLR, and ALC in Predicting ToF Primary Repair Outcome